Bulletin of the World Health Organization · 2026
Hepatitis A virus endemicity and vaccine policy, India.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Deoshatwar Avinash R, Pulinchani Anisha, Mathapati Basavaraj, Sudan Madhu, Mhatre Suman Manohar, Patil Anuradha, Hundekar Supriya, Sahoo Ganesh Chandra, Kumar Ashish, Sharma Sahil, Virk Amrit, Kayamkhani Mushtaq Khan, Choudhary Suresh, Khona Preet, Nuchin Jagadish Nuchin, Dutt Gopal, Kumar Prashant, Mishra Ragini, Singh Laisram Raichandra, Moirangthem Johnson, Dave Mruga, Jadhav Abhijeet V, Shrinivasa B, Arankalle Vidya, Lole Kavita S
Аннотация
OBJECTIVE: To estimate the age-stratified, hepatitis A virus (HAV) seroprevalence in eight Indian states.
METHODS: A cross-sectional seroprevalence survey was conducted in 120 rural and 105 urban population clusters across eight Indian states between 12 December 2022 and 28 November 2023. In each cluster, ten participants were randomly selected from each of the age groups: (i) 2 to 4 years; (ii) 5 to 9 years; (iii) 10 to 14 years; (iv) 15 to 30 years; and (v) > 30 years. Serum samples were tested for anti-HAV antibodies.
FINDINGS: Overall, the HAV seroprevalence in the five age groups was 33.2% (95% confidence interval, CI: 30.4-36.2), 51.9% (95% CI: 49.0-54.8), 69.2% (95% CI: 66.6-71.8), 89.7% (95% CI: 88.6-90.8) and 97.4% (95% CI: 96.9-97.8), respectively. The female-to-male ratio was 1.52 : 1 and the HAV seroprevalence was 73.0% (4940/6768) in females versus 63.2% (2821/4453) in males. Overall, HAV endemicity was found to be high-intermediate in study groups in Gujarat, Jammu, Karnataka, Punjab and Rajasthan, high in Bihar, intermediate in Assam and low-intermediate in rural Manipur. As the overall seroprevalence for all children younger than 15 years was 51.9%, substantially more than 40% were at risk of HAV infection.
CONCLUSION: Although HAV endemicity varied widely across urban and rural study populations in the eight Indian states, it was generally high-intermediate, providing evidence that HAV endemicity in India has declined in recent years. The study's findings could help Indian policy-makers decide on HAV vaccination for children.
METHODS: A cross-sectional seroprevalence survey was conducted in 120 rural and 105 urban population clusters across eight Indian states between 12 December 2022 and 28 November 2023. In each cluster, ten participants were randomly selected from each of the age groups: (i) 2 to 4 years; (ii) 5 to 9 years; (iii) 10 to 14 years; (iv) 15 to 30 years; and (v) > 30 years. Serum samples were tested for anti-HAV antibodies.
FINDINGS: Overall, the HAV seroprevalence in the five age groups was 33.2% (95% confidence interval, CI: 30.4-36.2), 51.9% (95% CI: 49.0-54.8), 69.2% (95% CI: 66.6-71.8), 89.7% (95% CI: 88.6-90.8) and 97.4% (95% CI: 96.9-97.8), respectively. The female-to-male ratio was 1.52 : 1 and the HAV seroprevalence was 73.0% (4940/6768) in females versus 63.2% (2821/4453) in males. Overall, HAV endemicity was found to be high-intermediate in study groups in Gujarat, Jammu, Karnataka, Punjab and Rajasthan, high in Bihar, intermediate in Assam and low-intermediate in rural Manipur. As the overall seroprevalence for all children younger than 15 years was 51.9%, substantially more than 40% were at risk of HAV infection.
CONCLUSION: Although HAV endemicity varied widely across urban and rural study populations in the eight Indian states, it was generally high-intermediate, providing evidence that HAV endemicity in India has declined in recent years. The study's findings could help Indian policy-makers decide on HAV vaccination for children.